Evidence map›Paper›PMID 36271599›Full record

ArticleThe Journal of international medical research2022

Fasting blood glucose as a predictor of progressive infarction in men with acute ischemic stroke.

Qiulong Yu, Xiaocheng Mao, Zhihui Fu, Si Luo, Qin Huang, Qianxi Chen, Shumeng Li, Jinchong Zhang, Yuexin Qiu, Yuhang Wu and 3 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Qiulong YuDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Xiaocheng MaoDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Zhihui FuDepartment of General Medicine, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Si LuoDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Qin HuangDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Qianxi ChenDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Shumeng LiDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Jinchong ZhangDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Yuexin QiuJiangxi Province Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang, Jiangxi, China.
Yuhang WuJiangxi Province Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang, Jiangxi, China.
Pu FangDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Daojun HongDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.
Jing LinDepartment of Neurology, First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China.ORCID 0000-0001-6272-1039
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBlood glucose is related to early neurological deterioration in acute ischemic stroke, but multiple mechanisms are involved in early neurological deterioration, such as progressive infarction. This study aimed to determine whether fasting blood glucose (FBG) is an independent predictor of progressive infarction.

methodsFrom April 2017 to December 2020, we retrospectively enrolled 477 patients with acute ischemic stroke within 48 hours of onset. Demographic characteristics, clinical information, neuroimaging characteristics, and laboratory data were collected after admission.

resultsWe found that 147 (30.8%) patients had progressive infarction. Multiple regression analysis showed that high FBG concentrations (>7.66 mmol/L) were independently associated with progressive infarction. Sex subgroup analysis showed that high FBG concentrations were an independent predictor of progressive infarction in male patients (odds ratio, 2.559; 95% confidence interval, 1.279-5.121). In a receiver operating characteristic curve analysis, FBG concentrations were a predictor of progressive infarction in all cases, especially in male patients. The cutoff value of FBG in all patients and men was 7.155 mmol/L.

conclusionsFBG is an independent predictor of progressive infarction in patients with acute ischemic stroke within 48 hours of onset, especially in men. Patients with FBG concentrations ≥7.155 mmol/L are more likely to develop progressive infarction.

Indexed as

HyperglycemiaIschemic StrokeStrokeBlood GlucoseFastingHumansInfarctionMaleRetrospective StudiesRisk FactorsBlood Glucoseacute ischemic strokeearly neurological deteriorationFasting blood glucosehyperglycemiaprogressive infarctionsex difference

Identifiers

PMID36271599
PMCPMC9597044
OpenAlexW4307136299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.